UK markets closed

HYLORIS PHARMA. S.A. (52U.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
14.50+0.75 (+5.45%)
As of 4:08PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
931
175
91
91
213
Cost of revenue
78
145
66
65
95
Gross profit
853
30
25
26
118
Operating expenses
Research development
3,801
3,413
4,577
4,870
2,313
Selling general and administrative
1,348
2,194
808
622
1,657
Total operating expenses
10,632
5,607
5,299
5,495
3,983
Operating income or loss
-9,779
-5,577
-5,274
-5,469
-3,865
Interest expense
573
992
411
340
146
Income before tax
-11,644
-7,145
-5,782
-6,059
-3,783
Income tax expense
0
1
-14
-20
-66
Income from continuing operations
-11,644
-7,146
-5,768
-6,039
-3,717
Net income
-11,643
-7,145
-5,373
-5,791
-3,717
Net income available to common shareholders
-11,643
-7,145
-5,373
-5,791
-3,717
Basic EPS
-
-0.33
-0.23
-0.25
-0.16
Diluted EPS
-
-0.33
-0.23
-0.25
-0.16
Basic average shares
-
21,819
23,552
23,552
23,552
Diluted average shares
-
21,819
23,552
23,552
23,552
EBITDA
-
-5,572
-2,065
-5,631
-3,572